Clinical Trials Browser

Lymphoma, B-Cell × decitabine and cedazuridine drug combination × 90 days × Clear all

NCT05272384 2026-03-18

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse